Showing 24441 - 24450 of 27841 for "Pharmaceuticals and life sciences" with applied filters
14 March 2024 by Bentsi-Enchill Letsa & Ankomah - Ghana
In this 2024 edition, we review the key market and regulatory developments from the 2023 financial year, consider how our projections for 2023 fared, and offer insights into the global and domestic trends which are shaping our outlook for business, legal and regulatory developments within the financial sector in 2024.
14 March 2024 by Bowmans - South Africa
Shortly after announcing its expansion into Namibia and, subsequently, the promotion of 13 partners, leading African law firm Bowmans has outlined the appointment of a new leadership team to drive it forward.
11 March 2024 by Walkers - Ireland
On 11 March 2024, the Central Bank of Ireland (the "Central Bank") reached a significant milestone in finalising its framework for authorisations under the revised European Long-Term Investment Funds Regulation (EU) 2023/606 ("ELTIF 2.0"). The Central Bank has published its Feedback Statement and its finalised ELTIF chapter contained in the latest version of the AIF Rulebook, alongside updating its website with details of the authorisation process and the Central Bank authorisation forms for ELTIF applications.
11 March 2024 by Cliffe Dekker Hofmeyr - South Africa
Leading corporate and commercial law firm, Cliffe Dekker Hofmeyr (CDH) continues to cement its market-leading position as one of South Africa’s top M&A legal advisers, according to the Ansarada DealMakers Annual Awards, held at the Sandton Convention Centre on 13 February 2024.
11 March 2024 by Zepos & Yannopoulos - Greece
Zepos & Yannopoulos acted, in cooperation with Milbank LLP, for the shareholders of BETA CAE Systems International AG (“BETA CAE”), a leading provider of multi-domain engineering simulation solutions, on the sale of BETA CAE to Cadence Design Systems, Inc (“Cadence”), a California-based leading EDA and Intelligent System Design provider.
11 March 2024 by Cliffe Dekker Hofmeyr - South Africa
Our experts' views on today's Budget Speech, compiled by CDH's Tax & Exchange Control practice.
11 March 2024 by Cliffe Dekker Hofmeyr - South Africa
One of the ways CDH demonstrates our commitment to the transformation of our society is through our dedicated Pro Bono & Human Rights Practice. We provide pro bono representation of the highest standard to deserving individuals, communities, NGOs and other organisations that promote human rights or the public interest.
11 March 2024 by Cliffe Dekker Hofmeyr
International Women's Day (IWD) is a global day celebrating the social, economic, cultural, and political achievements of women. The day also marks a call to action for accelerating gender parity.
08 March 2024 by Elias Neocleous & Co LLC - Cyprus
Elias Neocleous & Co LLC (ENC) and W11 Ventures (www.w11.ventures) are pleased to announce that they have entered into a powerful partnership to deliver strategic, multi-functional seed to scale advisory services to industry and investors from across the globe. This partnership combines ENC’s multidisciplinary legal expertise and tech-driven approach to solving complex legal challenges with W11’s world-class experience in business innovation strategy, groundbreaking technologies, governance, translational R&D, and investments.
07 March 2024 by Walkers - Ireland
On 7 March 2024, the Central Bank of Ireland (the "Central Bank") published its Prospectus Regulatory Framework – Questions & Answers 2nd Edition (the "Revised Q&A"). This document replaces the Prospectus Regulatory Framework Questions and Answers dated August 2017 (the "Original Q&A").